使用常规收集医疗卫生数据开展观察性研究的报告规范(药物流行病学版)RECORD-PE规范中文版(下)

被引：3

作者：

聂晓璐 ^{[1
]}

武泽昊 ^{[2
]}

赵厚宇 ^{[3
]}

詹思延 ^{[3
]}

孙凤 ^{[3
]}

彭晓霞 ^{[1
]}

机构：

[1] 国家儿童医学中心首都医科大学附属北京儿童医院临床流行病学与循证医学中心

[2] 首都医科大学公共卫生学院流行病与卫生统计学系

[3] 北京大学公共卫生学院院流行病与卫生统计学系

来源：

药物流行病学杂志 | 2019年 / 28卷 / 04期

基金：

北京市自然科学基金;

关键词：

常规医疗数据; 观察性研究; 报告规范; 药物流行病学;

D O I：

10.19960/j.cnki.issn1005-0698.2019.04.011

中图分类号：

R195.1 [卫生统计学];

学科分类号：

100401 ;

摘要：

<正>10方法(数据来源)10. 1 RECORD-PE规范条目8. a描述产生药物暴露记录的卫生保健系统及其机制。明确处方产生的临床场景。10. 2解释卫生保健系统的种类、可获得用药数据的患者特征和患者处方药报销的范围均可影响药物使用的可能性和研究数据中记录药物使用情况的可能性——如法规限制可能妨碍药物的使用。了解这一背景对于解释外推性或理解不同场景中药物可及性的局限

引用

页码：263 / 272

页数：10

共 42 条

[1]

Assumptions made when preparing drug exposure data for analysis have an impact on results: A n unreported step in pharmacoepidemiology studies[J] . Stephen R. Pye,Thérèse Sheppard,Rebecca M. Joseph,Mark Lunt,Nadyne Girard,Jennifer S. Haas,David W. Bates,David L. Buckeridge,Tjeerd P. Staa,Robyn Tamblyn,William G. Dixon.Pharmacoepidemiology and Drug Safety . 2018 (7)

[2]

Considerations for Pharmacoepidemiological Studies of Drug–Cancer Associations[J] . Anton Potteg?rd,S?ren Friis,Til Stürmer,Jesper Hallas,Shahram Bahmanyar.Basic ＆ Clinical Pharmacology ＆ Toxicology . 2018 (5)

[3]

Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials[J] . Tim Mathes,Stefanie Buehn,Peggy Prengel,Dawid Pieper.Journal of Clinical Epidemiology . 2018

[4]

Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review[J] . Nathalie Gault,Johann Casta?eda-Sanabria,Yann De Rycke,Sylvie Guillo,Stéphanie Foulon,Florence Tubach.BMC Medical Research Methodology . 2017 (1)

[5]

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0[J] . Shirley V. Wang,Sebastian Schneeweiss,Marc L. Berger,Jeffrey Brown,Frank Vries,Ian Douglas,Joshua J. Gagne,Rosa Gini,Olaf Klungel,C. Daniel Mullins,Michael D. Nguyen,Jeremy A. Rassen,Liam Smeeth,Miriam Sturkenboom.Pharmacoepidemiology and Drug Safety . 2017 (9)

[6] Trends in Antibiotic Use by Birth Season and Birth Year [J].

Kinlaw, Alan C. ;

Sturmer, Til ;

Lund, Jennifer L. ;

Pedersen, Lars ;

Kappelman, Michael D. ;

Daniels, Julie L. ;

Froslev, Trine ;

Mack, Christina D. ;

Sorensen, Henrik Toft .

PEDIATRICS, 2017, 140 (03)

[7]

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study[J] . Anna But,Marie L. De Bruin,Marloes T. Bazelier,Vidar Hjellvik,Morten Andersen,Anssi Auvinen,Jakob Starup-Linde,Marjanka K. Schmidt,Kari Furu,Frank de Vries,?ystein Karlstad,Nils Ekstr?m,Jari Haukka.Diabetologia . 2017 (9)

[8]

Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution[J] . Henrik St?vring,Anton Potteg?rd,Jesper Hallas.Pharmacoepidemiology and Drug Safety . 2017 (8)

[9] Statin potency and the risk of hospitalization for community-acquired pneumonia [J].

Shin, Ju-Young ;

Eberg, Maria ;

Ernst, Pierre ;

Filion, Kristian B. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (06) :1319-1327

[10]

Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real‐world dabigatran data[J] . Martin Erik Nyeland,Mona Vestergaard Laursen,Torbj?rn Callréus.Pharmacoepidemiology and Drug Safety . 2017 (6)

← 1 2 3 4 5 →